Eisai
4523.T
#2008
Rank
A$14.15 B
Marketcap
A$50.23
Share price
-0.53%
Change (1 day)
9.15%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2026 (TTM): A$0.57 Billion

According to Eisai's latest financial reports the company's current earnings are A$5.44 Billion. In 2025 the company made an earning of A$0.64 Billion a decrease over its 2024 earnings that were of A$0.81 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.57 B-10.84%
2025 A$0.64 B-20.48%
2024 A$0.81 B2.42%
2023 A$0.79 B-2404.04%
2022 -A$34.39 Million-103.6%
2021 A$0.95 B-39.81%
2020 A$1.58 B7.44%
2019 A$1.47 B17.22%
2018 A$1.26 B86.16%
2017 A$0.67 B-23.52%
2016 A$0.88 B26.97%
2015 A$0.69 B22.3%
2014 A$0.57 B-46.07%
2013 A$1.05 B-21.85%
2012 A$1.35 B-20.59%
2011 A$1.70 B-8.91%
2010 A$1.87 B19.21%
2009 A$1.56 B